Csenge Advisory Group’s Core Laboratories CLB Stock Holding History

Csenge Advisory Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11	Closed	–	–	427
2018 Q3	$0	Buy	+11	New	+$1.24K	﹤0.01%	1120

Other funds holding CLB

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Csenge Advisory Group's CLB Position: Q4 2018 in Review

Csenge Advisory Group sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 11 shares.

Csenge Advisory Group first reported a position in CLB in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

Csenge Advisory Group reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 11 Core Laboratories shares in Q4 2018.
Csenge Advisory Group first reported a position in Core Laboratories in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Core Laboratories position peaked at $0 in Q3 2018.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.